Mepolizumab Cuts Asthma Flare-Ups in Disadvantaged Kids

(MedPage Today) -- PHOENIX -- Adding mepolizumab (Nucala) to guideline-based care reduced flare-ups in disadvantaged kids with exacerbation-prone, eosinophilic asthma, the yearlong MUPPITS-2 trial showed. In the randomized study of nearly 300...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news